NFLPA seeks full review of Jalen Hurts’ medical care

The NFL Players Association is asking for a full investigation into how the NFL and Philadelphia Eagles handled Jalen Hurts’ blood clot situation. Hurts played in Week 5 in London after being diagnosed with a superficial vein thrombosis, then later was treated for a deep vein thrombosis and bilateral pulmonary emboli, and he is expected to miss the rest of the season. The NFL defended its medical process and said the Eagles did not violate policy, but the union wants the facts reviewed before conclusions are made.

The union seeks a complete review of the quarterback’s care instead of accepting the league’s finding that team doctors followed rules. Hurts had a superficial calf vein clot before playing in London in Week 5. He later received treatment for a deeper clot and clots in both lungs, including blood thinners, and is expected to miss the rest of the season.

League medical chief Allen Sills dismissed the idea that outside pressure would make physicians endanger a player. The NFL reportedly determined Philadelphia did not violate policy and would not be disciplined. The union said it knew of no league review and argued facts should be established before conclusions.